Mr. David (Xiao Ying) Gao, Chief Executive Officer

Mr. Gao has served as BMP Sunstone’s Chief Executive Officer and one of our directors since February 2004. Previously he served as President and Chief Executive Officer of Abacus Investments, Ltd., a private wealth management company, from 2003 to 2004. From 1989 to 2002, Mr. Gao held various senior posts at Motorola including Vice President and Director, Integrated Electronic System Sector, Asia-Pacific operation; Motorola Asia Pacific Management Board, Management Board of Motorola Japan Ltd. and Motorola China Management Board.

Mr. Gao holds a BSC in Mechanical Engineering from the Beijing Institute of Technology, a BSC in Mechanical Engineering from Hanover University, Germany, and an M.B.A. from The Massachusetts Institute of Technology.

Zhijun Tong
President, Chairman and GM, Sunstone Tangshan Pharmaceutical Co., Ltd

Mr. Tong has served as one of our directors since February 2008 and in January 2010 he became Chairman and GM, Sunstone Tangshan Pharmaceutical Co., Ltd.  On July 13, 2010 Mr. Tong was appointed President. He used to work in Beijing municipal government, and keeps very good relationships with relevant divisions there. Mr. Tong Now has served as Chairman of Spain Qifa (investment) Corporation Ltd. since 1997; Chairman of Qifa (Hebei) faming Co., Ltd since 1998; Chairman of Qifa (Liaoning) seeds Center Co., Ltd since 2002; and Vice Chairman/Chairman of Sunstone (Tangshan) Pharmaceutical Co., Ltd since 1996.

Fred Powell, Chief Finance Officer

Mr. Powell has served as BMP Sunstone’s Chief Financial Officer since January 2005. And prior to this, he had been with Eximias Pharmaceutical Corporation as the CFO since May 2002. He was Senior Vice President, Finance and Administration, at InnaPhase where he was mainly responsible for all financial, internal control, HR, administrative, and legal affairs. At Premier Research Worldwide (PRWW), Mr. Powell served as CFO and helped PRWW become one of the nation’s leading clinical research organizations by leading the Company’s initial public offering and managing several acquisitions, including DLB, a clinical trial and data management software company.

From 1983 to 1989, Mr. Powell spent seven years at KPMG Peat Marwick as a Senior Manager responsible for directing the planning, coordination and deliver of audit management and technology services to clients in the pharmaceutical and services industries.

Mr. Powell graduated from Penn State University in 1983, with a Bachelor of Sciences in Accounting and is a Certified Public Accountant.

Ms. Yanping Zhao, Chief Operating Officer

Ms. Zhao has served as BMP Sunstone’s Corporate Vice President since October 2007. From 1992 until 2007, Ms. Zhao held various senior positions with Sino Biopharmaceutical Ltd, where she held senior posts of Vice President and Executive Director in the Corporation, Executive Director in Shandong Chia Tai Freda Pharmaceutical Ltd, as well as Managing Director of its subsidiaries. Ms. Zhao also served as Department Head at Inner Mongolia Medicine and Health Products Import Export Corporation, and Deputy Plan Manager at Inner Mongolia Yuanbaoshan Pharmaceutical Ltd during 1983 to 1992.

Ms. Zhao has a Pharmaceutical degree from Shenyang Pharmaceutical University and a MBA from Dalian University of Technology.

Martyn D. Greenacre
Chairman - Former Chairman, Europe, SmithKline Beecham

Martyn Greenacre has served as Chairman of the Board of Beijing Med-Pharm since July 2004. Since 2002, Mr. Greenacre has also served as Chairman of Life Mist LLC, a fire suppression equipment company. From 1997 to 2001 Mr. Greenacre served as Chief Executive Officer and director of Delsys Pharmaceutical Corporation, a formulation and drug delivery system company. From 1993 to 1997, Mr. Greenacre served as President and Chief Executive Officer of Zynaxis Inc., a biopharmaceutical company. From 1989 to 1992, Mr. Greenacre was Chairman Europe, SmithKline Beecham Pharmaceutical company. Mr. Greenacre joined Smith Kline & French in 1973, where he held positions of increasing responsibility in its European organization. Mr. Greenacre currently serves as a director of Acusphere, Inc., a drug delivery company, Cephalon Inc., a pharmaceutical company, Curis Inc., a biotechnology company, and Immune Response Corp, a vaccine company.

David (Xiao Ying)  Gao
Director - CEO, BMP Sunstone

Mr. Gao has served as BMP Sunstone’s Chief Executive Officer and one of our directors since February 2004. Previously he served as President and Chief Executive Officer of Abacus Investments, Ltd., a private wealth management company, from 2003 to 2004. From 1989 to 2002, Mr. Gao held various senior posts at Motorola including Vice President and Director, Integrated Electronic System Sector, Asia-Pacific operation; Motorola Asia Pacific Management Board, Management Board of Motorola Japan Ltd. and Motorola China Management Board.

Mr. Gao holds a BSC in Mechanical Engineering from the Beijing Institute of Technology, a BSC in Mechanical Engineering from Hanover University, Germany, and an M.B.A. from The Massachusetts Institute of Technology.

Frank J. Hollendoner
Director - Doughty Hanson & Co

Frank J. Hollendoner has served as one of our directors since February 2004. Mr. Hollendoner is a private investor. From 2000 to 2004, Mr. Hollendoner served as Chairman of the board of directors of Dr. Foster, a privately-held healthcare information systems company. From 1993 to 2002, Mr. Hollendoner served as Chairman of the board of directors of Doughty Hanson & Co., a London based investment company and buy-out firm. Since 1993 he has served as Chairman of the advisory committee and member of the investment committee of Doughty Hanson & Co. He has served as a director of Ionic Fuel Technology, Inc., a publicly-traded environmental technology company, since 1998. From 1996 to 1998, he served as Chairman of the board of directors of Norden Pac Industries AB. From 1990 to 1998, Mr. Hollendoner served as Executive Chairman of the board of directors of Independent Care Group.

John W. Stakes III, MD
Director - Associate Neurologist, Massachusetts General Hospital

John W. Stakes III, M.D., has served as one of our directors since February 2004. Dr. Stakes has served as an Associate Neurologist at Massachusetts General Hospital since 1990, as Director, Massachusetts General Hospital Sleep Disorders Laboratory, since 1982, and as Director, Specialty Care Development, Massachusetts General Physicians Organization, since 1995. He was a member of the Committee on Continuing Medical Education of the Harvard Medical School. Dr. Stakes has held a teaching position at the Harvard Medical School since 1975.

Albert Yeung
Director - Former Senior Executive in China for Global Pharmaceutical Companies including J&J, Xian-Janssen, GSK and BMS

Albert Yeung has served as one of our directors since August 2006. Mr. Yeung is President of Albert Yeung & Associates Consulting Co., Ltd. From April 2003 until December 2003, he was a consultant to Glaxo SmithKline China Co., Ltd. From December 1997 through March 2003, Mr. Yeung served as Vice President and General Manager, Tianjin SmithKline & French Co., Ltd. He has 30 years working experience in pharmaceutical marketing and management both in ethical and consumer medicine fields in China and Hong Kong. Mr. Yeung is a co-founder and Honorary Chairman of The Shanghai Psycho-social Rehabilitation Association and Honorary Member of The Shanghai Chinese Traditional and Western Medicine Association.

Zhijun Tong
President, Chairman and GM, Sunstone Tangshan Pharmaceutical Co., Ltd

Mr. Tong has served as one of our directors since February 2008 and in January 2010 he became Chairman and GM, Sunstone Tangshan Pharmaceutical Co., Ltd.  On July 13, 2010 Mr. Tong was appointed President. He used to work in Beijing municipal government, and keeps very good relationships with relevant divisions there. Mr. Tong Now has served as Chairman of Spain Qifa (investment) Corporation Ltd. since 1997; Chairman of Qifa (Hebei) faming Co., Ltd since 1998; Chairman of Qifa (Liaoning) seeds Center Co., Ltd since 2002; and Vice Chairman/Chairman of Sunstone (Tangshan) Pharmaceutical Co., Ltd since 1996.

Les R. Baledge
Director

Mr. Baledge has over two decades of experience in corporate law. From 1999 to 2004, Mr. Baledge served as Executive Vice President and General Counsel for Tyson Foods, a leading multinational food company. Prior to that, he was counsel to Kutak Rock LLP. From 1981 to 1998, he served as a partner at the Rose Law Firm, where he advised numerous public and private companies. Mr. Baledge received his J.D. and B.A. from the University of Arkansas. He is currently an active private investor.

Daniel P. Harrington
Director

Mr. Harrington has more than thirty years of management experience, including extensive experience working with publicly traded companies. Since 1995, he has been President and CEO of HTV Industries, a diversified holding company with interests in manufacturing, distribution and banking. Mr. Harrington is a CPA and began his career at Arthur Andersen & Co. Mr. Harrington is a Board Director of Churchill Downs (NASDAQ: CHDN) and Portec Rail Products, Inc. (NASDAQ: PRPX).